Product Information
ETHACRYNIC ACID 25 MG TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.8066 per EA under NDC 68180015901. Its NADAC has been published 337 times since Apr 22, 2020.
FDA first approved this application on Sep 6, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25 mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180015901
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ETHACRYNIC ACIDApproval Type
Generic (ANDA)
FDA Application
ANDA211719FDA Approved
9/6/2019
TE Code
AB
On Market Since
2/24/2020
Pharmacological Classes
Price Statistics
The NADAC for ETHACRYNIC ACID 25 MG TABLET has been published 337 times since Apr 22, 2020, and over the history we have for it it has declined 91.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8066 per EA |
|---|---|
| All-time high | $9.8099 (May 13, 2020) |
| All-time low | $0.7573 (Jul 22, 2026) |
| 52-week high | $0.9935 |
| 52-week low | $0.7573 |
| Median price | $1.6144 |
| Average price | $2.5555 |
| Largest weekly change | +47.4% (Aug 19, 2020) |
| Weeks tracked | 337 |
| Tracking since | Apr 22, 2020 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lupin Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ethacrynic Acid market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Loop Diuretic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ETHACRYNIC ACID 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ETHACRYNIC ACID 25 MG TABLET, manufactured by Lupin Pharmaceuticals Inc., is $0.8066 per EA (NDC 68180015901), effective Sep 30, 2026.
How has the price of ETHACRYNIC ACID 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for ETHACRYNIC ACID 25 MG TABLET has declined 91.8%. It has been tracked across 337 weekly CMS publications since Apr 22, 2020.
What are the highest and lowest recorded NADAC prices for ETHACRYNIC ACID 25 MG TABLET?
Since Apr 22, 2020, the NADAC for ETHACRYNIC ACID 25 MG TABLET has ranged from a low of $0.7573 (Jul 22, 2026) to a high of $9.8099 (May 13, 2020), with a median of $1.6144 per EA.
Are there cheaper alternatives to ETHACRYNIC ACID 25 MG TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ETHACRYNIC ACID 25 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ETHACRYNIC ACID 25 MG TABLET?
ETHACRYNIC ACID 25 MG TABLET (NDC 68180015901) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.